Identification and Characterization of in vitro Metabolites of Belinostat by Rat Liver Microsomes using Ultra Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry
1, 2, 2, 3, 4
- 1Department of Pharmaceutical Sciences, KIET School of Pharmacy, KIET Group of Institutions, Delhi-NCR, Ghaziabad.
- 2Department of Pharmaceutical Sciences, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, INDIA.
- 3Department of Regulatory Affairs, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, INDIA.
- 4Department of DMPK and Bioanalytical, Dabur Research Foundation, Sahibabad, Ghaziabad, Uttar Pradesh, INDIA.
CORRESPONDENCE
Lovekesh Mehta
Department of Pharmaceutical Sciences, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, INDIA.
Received: 01-06-2021; Accepted: 09-11-2021.
Volume 56, Issue 1s (Supplement) · pp. S58-S66 · 2022 · DOI: 10.5530/ijper.56.1s.43
ABSTRACT
Objectives: The objective of the present study is to study the in-vitro metabolites of FDA approved anticancer drug, belinostat which is a histone deacetylase inhibitor.Methods: The metabolites were formed by incubating the drug, belinostat with rat liver microsomes, at 37°C for 24 hr. The newly formed metabolites were identified and characterized with the help of ultra-high performance liquid chromatography which is interlinked with tandem quadrupole time-of-flight mass spectrometry.Results: Two Phase-I metabolites were formed which include a belinostat amide (reductive metabolite) and belinostat acid (deaminated belinostat). We then elucidated the structures of the formed metabolites based on LC-MS/MS data which included accurate masses, the fragmentation of ions and chromatographic retention times.Conclusion: This study describes the detailed in-vitro metabolite profiling of belinostat which will be further helpful to predict the in-vivo metabolism of belinostat in the human body. Enzyme kinetic parameters (Km and Vmax) for both the metabolites were also established using different substrate concentrations. The study will be helpful in determining the safety and efficacy of the drug. This will further help in determining the elimination mechanism of belinostat which in turn will assist in predicting the effectiveness and toxicity of the drug.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Grover, P., Mehta, L., Naved, T., Kumar, S., & Monga, G. (2022). Identification and Characterization of in vitro Metabolites of Belinostat by Rat Liver Microsomes using Ultra Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry. Indian Journal of Pharmaceutical Education and Research, 56(1s), S58-S66. https://doi.org/10.5530/ijper.56.1s.43
Copyright and licence
© 2022 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0